Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogenic Bone Marrow Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00423709
What this trial is testing

Allogeneic Blood Stem Cell Transplantation

Who this might be right for
Hodgkin's Disease
M.D. Anderson Cancer Center 46
Large-scale testing (Phase 3)Ended earlyNCT05179057
What this trial is testing

Posoleucel (ALVR105) for the Treatment of Adenovirus Infection in Pediatric and Adult Participants Receiving Standard of Care Following Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Adenovirus Infection
AlloVir 57
Not applicableStudy completedNCT03904134
What this trial is testing

Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndromes+4 more
Center for International Blood and Marrow Transplant Research 1,753
Early research (Phase 1)Study completedNCT00004232
What this trial is testing

Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Northwestern University
Early research (Phase 1)Study completedNCT00641030
What this trial is testing

Clofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Myelodysplastic Syndromes

Who this might be right for
LeukemiaMyelodysplastic Syndromes
City of Hope Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT00144677
What this trial is testing

Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation

Who this might be right for
Acute Myelogenous LeukemiaGraft Versus Host DiseaseAcute Lymphoblastic Leukemia+4 more
Dana-Farber Cancer Institute 30
Early research (Phase 1)Study completedNCT02312102
What this trial is testing

Velcade and Lenalidomide in Patients With Relapsed AML and MDS After Allogeneic Stem Cell Transplantation

Who this might be right for
Myelodysplastic SyndromeAcute Myeloid Leukemia
Massachusetts General Hospital 22
Testing effectiveness (Phase 2)Study completedNCT00004896
What this trial is testing

Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Northwestern University
Not applicableEnded earlyNCT00301860
What this trial is testing

Donor Stem Cell Transplant Followed By Donor White Blood Cell Infusions in Treating Young Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphoma
University of California, San Francisco 8
Testing effectiveness (Phase 2)Ended earlyNCT00167180
What this trial is testing

Post Transplant Donor Lymphocyte Infusion

Who this might be right for
Leukemia, Myeloid, ChronicLymphomasMultiple Myeloma+4 more
Masonic Cancer Center, University of Minnesota 57
Early research (Phase 1)Study completedNCT02916979
What this trial is testing

Myeloid-Derived Suppressor Cells and Checkpoint Immune Regulators' Expression in Allogeneic SCT Using FluBuATG

Who this might be right for
Leukemia, LymphoidLeukemia, MyeloidMyelodysplastic Syndromes+4 more
Dartmouth-Hitchcock Medical Center 20
Testing effectiveness (Phase 2)Ended earlyNCT00185679
What this trial is testing

Haploid Allogeneic Transplant Using the CliniMACS System

Who this might be right for
Acute Myelogenous Leukemia (AML) - Relapsed, Primary Refractory Disease or Poor Risk FactorsChronic Myelogenous Leukemia (CML) - Accelerated or Second Chronic PhaseMyelodysplastic Syndrome (MDS) - High and Intermediate Risk+2 more
Ginna Laport 13
Testing effectiveness (Phase 2)Ended earlyNCT01622556
What this trial is testing

Conditioning Treatment With Umbilical Cord Blood Transplant for Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
University of Virginia 6
Testing effectiveness (Phase 2)Looking for participantsNCT05027945
What this trial is testing

A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome

Who this might be right for
ImmunodeficiencyHematopoietic Stem Cell Transplantation
National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)Study completedNCT01814475
What this trial is testing

Study to Compare Busulfan-fludarabine With Thiotepa-fludarabine Regimen in Allogeneic Transplantation for Myelofibrosis

Who this might be right for
Myelofibrosis
Gruppo Italiano Trapianto di Midollo Osseo 62
Not applicableActive Not RecruitingNCT01199562
What this trial is testing

Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant

Who this might be right for
Hematopoietic/Lymphoid CancerAccelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated Leukemia+151 more
City of Hope Medical Center 153
Testing effectiveness (Phase 2)Study completedNCT00822770
What this trial is testing

Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin

Who this might be right for
Stem Cell TransplantationLeukemia
M.D. Anderson Cancer Center 47
Large-scale testing (Phase 3)Study completedNCT00169728
What this trial is testing

Vaccination of Children Following Allogeneic Stem Cell Transplantation

Who this might be right for
Allogeneic Haematopoietic Stem Cell Transplantation
Heinrich-Heine University, Duesseldorf 53
Testing effectiveness (Phase 2)Ended earlyNCT02323477
What this trial is testing

Human Umbilical Cord Stroma MSC in Myocardial Infarction

Who this might be right for
Chronic Ischemic CardiomyopathyCoronary Artery Bypass Surgery
Ankara University 46
Large-scale testing (Phase 3)UnknownNCT02270307
What this trial is testing

MSC and Cyclophosphamide for Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis

Who this might be right for
LeukemiaMultiple Myeloma
National Research Center for Hematology, Russia 40
Next Page